Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Matinas BioPharma's price to book ratio was 3.3× on Nov 11, 2026, against 10.3× a year earlier. Over the last 5 years it ranged from 2.4× to 60.0×, with a median of 25.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | −4.7 |
| 2025 | Dec 31, 2025 | 8.0× | +5.6 |
| 2024 | Dec 31, 2024 | 2.5× | −28.0 |
| 2023 | Dec 29, 2023 | 30.4× | −11.7 |
| 2022 | Dec 30, 2022 | 42.1× | −14.1 |
| 2021 | Dec 31, 2021 | 56.2× | −3.3 |
| 2020 | Dec 31, 2020 | 59.5× | −86.4 |
| 2019 | Dec 31, 2019 | 145.9× | +61.2 |
| 2018 | Dec 31, 2018 | 84.6× | −41.9 |
| 2017 | Dec 29, 2017 | 126.5× | −12.9 |
| 2016 | Dec 30, 2016 | 139.4× | – |
See a number that looks wrong?